세계의 돼지 백신 시장 보고서(2025년)

A swine vaccine is a formulation given or injected into pigs to provoke an immune response against a particular infectious agent. These vaccines play a vital role in preventing diseases that can adversely affect pig health, productivity, and overall herd management.

The primary types of swine vaccines include attenuated live vaccines, inactivated vaccines, subunit vaccines, DNA vaccines, and recombinant vaccines. Attenuated live vaccines consist of weakened living viruses or bacteria that have been altered to reduce their pathogenicity. These vaccines aim to trigger a robust immune response in pigs by replicating within the body, leading to prolonged immunity. They are effective against various diseases including viral, bacterial, parasitic, and fungal infections. Swine vaccines are distributed through veterinary hospitals, veterinary pharmacies, and online pharmacies. These products are available through government tenders and sales in the market.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The swine vaccines market research report is one of a series of new reports from The Business Research Company that provides swine vaccines market statistics, including swine vaccines industry global market size, regional shares, competitors with a swine vaccines market share, detailed swine vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the swine vaccines industry. This swine vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The swine vaccines market size has grown strongly in recent years. It will grow from $2.18 billion in 2024 to $2.37 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to disease outbreaks, economic losses, government regulations, increased swine production.

The swine vaccines market size is expected to see strong growth in the next few years. It will grow to $3.41 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to emerging diseases and viral strains, globalization of swine industry, climate and environmental changes, biosecurity measures, market competition. Major trends in the forecast period include veterinary advancements, evolving disease patterns, global demand for protein, technological advancements, preventive healthcare focus.

The forecast of 9.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers on cold-chain distribution tools and vaccine-grade biochemicals may inflate costs and reduce vaccine access across swine production systems. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing incidence of diseases in swine is anticipated to drive the swine vaccine market in the future. Swine disease refers to any deviation from the normal structural or functional condition of an organism, often accompanied by signs and symptoms of ailments such as pseudorabies and influenza. Swine vaccines effectively address the increasing prevalence of these diseases by stimulating the immune system to recognize and respond to specific pathogens, thus reducing infection rates, alleviating disease severity, and promoting overall herd health. For example, in December 2023, the Swine Health Information Center, a US-based organization, reported a concerning rise in cases of African Swine Fever (ASF) among wild boars in Poland. By early 2023, the country had recorded 2,347 confirmed ASF cases in wild boars, surpassing the total from 2022. Consequently, the rising prevalence of diseases in swine is expected to boost market growth.

The rising global consumption of pork is expected to contribute to the growth of the swine vaccine market in the future. Pork consumption involves individuals incorporating pork into their diet through the preparation and consumption of various pork products sourced from pigs. Swine vaccines are essential for maintaining the health of pig populations, minimizing the risk of disease outbreaks, and ensuring the production of safe, high-quality pork worldwide. For instance, in March 2023, the Food and Agriculture Organization, an Italy-based federal organization, stated that pork constituted approximately 36% of the meat consumed globally, totaling 112.6 kilotons, with projections to increase to 129 kilotons by 2031. Therefore, the rising global pork consumption is driving the growth of the swine vaccine market.

Technological innovation is a significant trend gaining traction in the swine vaccine market. Leading companies are focusing on developing advanced technologies that enable the simultaneous delivery of two vaccines to enhance swine health and maintain their market position. For instance, in May 2022, Boehringer Ingelheim, a Germany-based pharmaceutical firm, introduced TwistPak technology. TwistPak is a groundbreaking platform that combines two vaccines, IngelvacCircoFLEX and IngelvacMycoFLEX, specifically for swine producers. This technology provides a convenient and time-efficient solution, facilitating a simplified mixing process while allowing flexibility to use the products either as a combined vaccine or as individual monovalent options. It is produced using advanced technologies and features an ergonomic design.

Prominent companies in the swine vaccine market are increasingly prioritizing the introduction of innovative vaccines, such as Circumvent CML, to enhance their competitive advantage. Circumvent CML is a vaccine aimed at safeguarding swine herds against various diseases, thereby improving overall swine health and productivity. For example, in June 2023, Merck Animal Health, a US-based pharmaceutical company, launched a new 3-in-one swine vaccine named Circumvent CML, which addresses the diseases caused by Porcine Circovirus Type 2a (PCV-2a), Porcine Circovirus Type 2d (PCV-2d), Mycoplasma hyopneumoniae, and Lawsonia intracellularis. This new vaccine is founded on Merck's established, proven antigens and adjuvant systems that have been utilized in Circumvent PCV-M G2 and their standalone product, Porcilis Ileitis.

In July 2024, MSD Animal Health, a US-based biopharmaceutical firm, acquired Elanco's aqua business for $1.3 billion. Through this acquisition, MSD Animal Health aims to substantially strengthen its presence in the aquaculture sector by broadening its range of products and solutions designed to enhance fish health, welfare, and sustainability. Elanco is a US-based pharmaceutical company that specializes in providing vaccine solutions for swine.

Major companies operating in the swine vaccines market are Merck & Co Inc., Boehringer Ingelheim Animal Health USA Inc., Elanco Animal Health Inc., Biogenesis Bago SA, Phibro Animal Health Corporation, KM Biologics Co. Ltd., Hipra Laboratories SA, Ceva Sante Animale SA, Zoetis Inc., Jinyu Bio-Technology Co. Ltd., China Animal Husbandry Industry Co. Ltd., Virbac SA, Harbin Veterinary Research Institute, Bioveta AS, Bimeda Holdings PLC, Biovac Ltd., Hester Biosciences Limited, Hygieia Biological Laboratories, IDT Biologika GmbH, Intervet Inc., Komipharm International Co. Ltd., Kyoritsu Seiyaku Corporation, Lohmann Animal Health International, Norbrook Laboratories Limited, Ouro Fino Saude Animal SA, Prondil SA, Vaxxinova International BV, Vetoquinol SA, Veyx Pharma GmbH, Tianjin Ringpu Bio-Technology Co. Ltd.

North America was the largest region in the swine vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the swine vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the swine vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The swine vaccine market consists of sales of haemophilus parasuis, pasteurella, salmonella, and streptococcus suis. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Swine Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on swine vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for swine vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The swine vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Attenuated Live Vaccines; Inactivated Vaccines; Subunit Vaccines; DNA (Deoxyribonucleic Acid) Vaccines; Recombinant Vaccines
• 2) By Disease: Viral Infections; Bacterial Infections; Parasitic Infection; Fungal Infections; Other Diseases
• 3) By Distribution Channel: Veterinary Hospitals; Veterinary Pharmacies; Online Pharmacies
• 4) By Application: Government Tender; Market Sales
• Subsegments:
• 1) By Attenuated Live Vaccines: Live Attenuated Virus Vaccines; Live Attenuated Bacterial Vaccines
• 2) By Inactivated Vaccines: Whole Inactivated Virus Vaccines; Inactivated Bacterial Vaccines
• 3) By Subunit Vaccines: Protein Subunit Vaccines; Polysaccharide Subunit Vaccines
• 4) By DNA (Deoxyribonucleic Acid) Vaccines: Plasmid DNA Vaccines; Nucleic Acid Vaccines
• 5) By Recombinant Vaccines: Recombinant Vector Vaccines; Recombinant Protein Vaccines
• Companies Mentioned: Merck & Co Inc.; Boehringer Ingelheim Animal Health USA Inc.; Elanco Animal Health Inc.; Biogenesis Bago SA; Phibro Animal Health Corporation; KM Biologics Co. Ltd.; Hipra Laboratories SA; Ceva Sante Animale SA; Zoetis Inc.; Jinyu Bio-Technology Co. Ltd.; China Animal Husbandry Industry Co. Ltd.; Virbac SA; Harbin Veterinary Research Institute; Bioveta AS; Bimeda Holdings PLC; Biovac Ltd.; Hester Biosciences Limited; Hygieia Biological Laboratories; IDT Biologika GmbH; Intervet Inc.; Komipharm International Co. Ltd.; Kyoritsu Seiyaku Corporation; Lohmann Animal Health International; Norbrook Laboratories Limited; Ouro Fino Saude Animal SA; Prondil SA; Vaxxinova International BV; Vetoquinol SA; Veyx Pharma GmbH; Tianjin Ringpu Bio-Technology Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Swine Vaccines Market Characteristics

3. Swine Vaccines Market Trends And Strategies

4. Swine Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Swine Vaccines Growth Analysis And Strategic Analysis Framework

• 5.1. Global Swine Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Swine Vaccines Market Growth Rate Analysis
• 5.4. Global Swine Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Swine Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Swine Vaccines Total Addressable Market (TAM)

6. Swine Vaccines Market Segmentation

• 6.1. Global Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA (Deoxyribonucleic Acid) Vaccines
• Recombinant Vaccines
• 6.2. Global Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Viral Infections
• Bacterial Infections
• Parasitic Infection
• Fungal Infections
• Other Diseases
• 6.3. Global Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Veterinary Hospitals
• Veterinary Pharmacies
• Online Pharmacies
• 6.4. Global Swine Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Government Tender
• Market Sales
• 6.5. Global Swine Vaccines Market, Sub-Segmentation Of Attenuated Live Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Live Attenuated Virus Vaccines
• Live Attenuated Bacterial Vaccines
• 6.6. Global Swine Vaccines Market, Sub-Segmentation Of Inactivated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Whole Inactivated Virus Vaccines
• Inactivated Bacterial Vaccines
• 6.7. Global Swine Vaccines Market, Sub-Segmentation Of Subunit Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Protein Subunit Vaccines
• Polysaccharide Subunit Vaccines
• 6.8. Global Swine Vaccines Market, Sub-Segmentation Of DNA (Deoxyribonucleic Acid) Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plasmid DNA Vaccines
• Nucleic Acid Vaccines
• 6.9. Global Swine Vaccines Market, Sub-Segmentation Of Recombinant Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant Vector Vaccines
• Recombinant Protein Vaccines

7. Swine Vaccines Market Regional And Country Analysis

• 7.1. Global Swine Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Swine Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Swine Vaccines Market

• 8.1. Asia-Pacific Swine Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Swine Vaccines Market

• 9.1. China Swine Vaccines Market Overview
• 9.2. China Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Swine Vaccines Market

• 10.1. India Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Swine Vaccines Market

• 11.1. Japan Swine Vaccines Market Overview
• 11.2. Japan Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Swine Vaccines Market

• 12.1. Australia Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Swine Vaccines Market

• 13.1. Indonesia Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Swine Vaccines Market

• 14.1. South Korea Swine Vaccines Market Overview
• 14.2. South Korea Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Swine Vaccines Market

• 15.1. Western Europe Swine Vaccines Market Overview
• 15.2. Western Europe Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Swine Vaccines Market

• 16.1. UK Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Swine Vaccines Market

• 17.1. Germany Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Swine Vaccines Market

• 18.1. France Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Swine Vaccines Market

• 19.1. Italy Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Swine Vaccines Market

• 20.1. Spain Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Swine Vaccines Market

• 21.1. Eastern Europe Swine Vaccines Market Overview
• 21.2. Eastern Europe Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Swine Vaccines Market

• 22.1. Russia Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Swine Vaccines Market

• 23.1. North America Swine Vaccines Market Overview
• 23.2. North America Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Swine Vaccines Market

• 24.1. USA Swine Vaccines Market Overview
• 24.2. USA Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Swine Vaccines Market

• 25.1. Canada Swine Vaccines Market Overview
• 25.2. Canada Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Swine Vaccines Market

• 26.1. South America Swine Vaccines Market Overview
• 26.2. South America Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Swine Vaccines Market

• 27.1. Brazil Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Swine Vaccines Market

• 28.1. Middle East Swine Vaccines Market Overview
• 28.2. Middle East Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Swine Vaccines Market

• 29.1. Africa Swine Vaccines Market Overview
• 29.2. Africa Swine Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Swine Vaccines Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Swine Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Swine Vaccines Market Competitive Landscape And Company Profiles

• 30.1. Swine Vaccines Market Competitive Landscape
• 30.2. Swine Vaccines Market Company Profiles
  • 30.2.1. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Boehringer Ingelheim Animal Health USA Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Elanco Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Biogenesis Bago SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Phibro Animal Health Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Swine Vaccines Market Other Major And Innovative Companies

• 31.1. KM Biologics Co. Ltd.
• 31.2. Hipra Laboratories SA
• 31.3. Ceva Sante Animale SA
• 31.4. Zoetis Inc.
• 31.5. Jinyu Bio-Technology Co. Ltd.
• 31.6. China Animal Husbandry Industry Co. Ltd.
• 31.7. Virbac SA
• 31.8. Harbin Veterinary Research Institute
• 31.9. Bioveta AS
• 31.10. Bimeda Holdings PLC
• 31.11. Biovac Ltd.
• 31.12. Hester Biosciences Limited
• 31.13. Hygieia Biological Laboratories
• 31.14. IDT Biologika GmbH
• 31.15. Intervet Inc.

32. Global Swine Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Swine Vaccines Market

34. Recent Developments In The Swine Vaccines Market

35. Swine Vaccines Market High Potential Countries, Segments and Strategies

• 35.1 Swine Vaccines Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Swine Vaccines Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Swine Vaccines Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer